Chicago

77 West Wacker Drive
Suite 3200
Chicago, IL 60601
T: +1 312 646 5800
F: +1 312 646 5858

Office Managing Partner

  • T: +1 312 646 5811
    F: +1 312 646 5858

The opening of Dechert’s Chicago office in 2012 marked both the firm’s expansion into the Midwest as well as a significant enhancement of our white collar and securities litigation capabilities.

Our Chicago team focuses on defending public companies, their directors and officers in securities class actions, Securities and Exchange Commission investigations, corporate governance and related disputes. We also handle commercial litigation matters, including product liability and class actions involving allegations of unfair consumer practices.

Areas of Focus

Class Actions

Dechert’s trial lawyers have defended significant class actions in a variety of industries. We handle every phase of a class action, from defeating certification and achieving de-certification on appeal to securing defense jury verdicts in complex class action trials. We have defeated class certification in more than 30 different state and federal jurisdictions and successfully handled class actions of every major type across industries.

Complex Commercial Litigation

We represent a range of industries in commercial agreements, consumer fraud, insurance and banking, false advertising, corporate governance and M&A-related claims. Recognized for our multi-jurisdictional capabilities and deep expertise, we devise litigation strategy, manage virtual law firms, facilitate pre-trial resolutions to commercial disputes, defeat class certification, manage e-discovery, obtain summary judgments or voluntary dismissal of claims, negotiate favorable settlements and prevail at trial.

Product Liability and Mass Torts

Dechert’s well-established product liability and mass torts group helps clients avoid exposure and defends them when litigation occurs. Our work is particularly focused on prescription drugs and devices, biologics, chemicals, toxic substances emissions, consumer products and durable goods. We also handle cases involving latent injuries and complex issues of medical causation.

Securities Litigation and Enforcement

One of the few firms with a longstanding securities practice, Dechert is recognized as one of the foremost defenders against complex, high-stakes litigation in the country. Our experienced lawyers, many of whom have held senior positions at the SEC, DOJ and other agencies, bring an invaluable perspective and credibility that comes from being in the shoes of government decision makers.

We represent public and private corporations, private equity funds, officers and directors, special committees and professional service firms in securities litigation, securities enforcement matters, corporate governance, fiduciary, mergers and acquisitions, and banking and financial institution litigation.

White Collar and Investigations

Dechert’s acclaimed white collar lawyers defend clients facing allegations of financial and business crimes and related civil and class action litigation. We handle all phases of an investigation, and when litigation is unavoidable, implement a comprehensive strategy of relentless advocacy to secure the interests and well-being of our clients. Our internal investigations team has an impressive track record of resolving these difficult and sensitive matters discreetly and favorably without prosecution.

We advise boards of directors, special committees and senior executives on critical decisions involving white collar and related matters. Our experienced team includes former Assistant U.S. Attorneys for the Criminal Division, Major Frauds Section, Securities and Commodities Fraud Unit, and various U.S. Attorneys’ Offices and task forces of the Department of Justice.

Life Sciences

We provide comprehensive legal services to clients involved in all aspects of the life sciences industry, including biotechnology, bio-informatics, drug discovery, genomics, biopharmaceutical, diagnostic and medical device companies. We advise on the complex commercial, legal and regulatory issues facing life sciences companies at all stages of growth, as well as on the development and commercialization of new technologies.